Achillion Pharmaceuticals
ACHN
ACHN was delisted on the 27th of January, 2020.
158 hedge funds and large institutions have $950M invested in Achillion Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 62 increasing their positions, 43 reducing their positions, and 41 closing their positions.
101% more call options, than puts
Call options by funds: $37.5M | Put options by funds: $18.6M
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
44% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 43
8% less capital invested
Capital invested by funds: $1.04B → $950M (-$85.4M)
9% less funds holding
Funds holding: 173 → 158 (-15)
10.6% less ownership
Funds ownership: 89.27% → 78.67% (-11%)
37% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 41
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$79.3M |
| 2 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$17.5M |
| 3 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$17.1M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$16.4M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$12.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$29.2M |
| 2 |
DM
Deerfield Management
New York
|
-$27.7M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$24.2M |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$22.9M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$16.3M |
ACHN Hedge Fund Activity: Q2 2015 in Review
158 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Achillion Pharmaceuticals (ACHN) for Q2 2015, worth a combined $950M — down 8.2% from $1.04B a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of ACHN and 26 opened new positions — a net loss of 15 holders — while 43 trimmed existing stakes and 62 added.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $79.3M. The largest seller was Sectoral Asset Management, cutting an estimated $29.2M.
- 158 institutional investors held Achillion Pharmaceuticals (ACHN) as of Q2 2015, down from 173 in Q1 2015.
- Funds reported $950M of Achillion Pharmaceuticals stock for Q2 2015, down 8.2% quarter-over-quarter.
- 26 funds opened new Achillion Pharmaceuticals positions in Q2 2015 and 41 closed out, a net change of -15 holders.
- The largest Achillion Pharmaceuticals buyer in Q2 2015 was Point72 Asset Management, an estimated $79.3M added.
- The largest Achillion Pharmaceuticals seller in Q2 2015 was Sectoral Asset Management, an estimated $29.2M sold.
Based on aggregated 13F filings for Q2 2015.